The Health Ministry of Brazil has signed a contract on 25 February 2021, to purchase 20 million doses of Covaxin, the COVID-19 vaccine made by India's Bharat Biotech, for delivery between March and May 2021, Reuter's news agency reported on Friday.
In a statement, the Health Ministry said that the deal is worth USD290,000, with the first eight million doses expected to arrive in March 2021.
The Health Ministry added that to speed up the process of buying of COVID-19 vaccines in Brazil and to deal with the COVID-19 outbreak, it had published new rules last week dispensing with the bidding process.
As of 25 February 2021, Brazil reported 1,541 new COVID-19 deaths, the second highest daily death toll since the pandemic began, taking total fatalities to 251,498.
Brazil also added 65,998 new cases, registering a total of 10,390,461 COVID-19 cases, the world's third worst outbreak after the US and India.
EpiVax introduces AI-enhanced models for immunogenicity prediction
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070